Literature DB >> 12352079

Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty.

Claus Cursiefen1, Peter Martus, Nhung X Nguyen, Achim Langenbucher, Berthold Seitz, Michael Küchle.   

Abstract

PURPOSE: To analyze the influence of mechanical versus nonmechanical trephination of donor and host corneas on superficial, peripheral corneal neovascularization occurring after non-high-risk keratoplasty.
METHODS: Patients of the prospective Erlangen non-high-risk keratoplasty study with standardized corneal photographs taken preoperatively and 1 year later were analyzed (n = 184). Slides of these photographs were projected (magnification x100) and corneal vessels graded in a standardized semiquantitative fashion into five categories with regard to limbus, sutures, and host-graft junction in each of 12 corneal sectors. Degree (total increase of grades in the 12 sectors) and maximal extent of corneal neovascularization (maximal centripetal extension of blood vessels) were analyzed. In 32 patients mechanical (17%) and in 152 nonmechanical trephination of host and donor tissue was performed (193-nm excimer laser, 83%). Statistical analysis was done using Fisher's exact and Mann-Whitney test.
RESULTS: Corneal neovascularization within the first postoperative year was lower in the nonmechanical [73 of 152 (48%)] compared with mechanical trephination group [24 of 32 (75%); p< 0.01; Mann-Whitney test]. Maximal extent of neovascularization (i.e., vessels reaching the interface or growing beyond) was not yet significantly different between nonmechanical (8%) and mechanical (17%) trephination (p = 0.074).
CONCLUSIONS: Nonmechanical trephination using the 193-nm excimer laser in non-high-risk keratoplasties might reduce corneal neovascularization occurring within the first postoperative year. This indicates that in the non-high-risk setting, development of postoperative corneal neovascularization may be affected by the trephination technique and subsequent wound-healing response.

Entities:  

Mesh:

Year:  2002        PMID: 12352079     DOI: 10.1097/00003226-200210000-00003

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

Review 1.  [Topical inhibition of angiogenesis at the cornea. Safety and efficacy].

Authors:  B Regenfuss; F Bock; B Bachmann; Y König; D Hos; A Parthasarathy; C Cursiefen
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

Review 2.  [Antiangiogenic therapy at the ocular surface: when, what and why?].

Authors:  F Bock; B Regenfuss; C Cursiefen
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

Review 3.  [Inhibition of angiogenesis in the anterior chamber of the eye].

Authors:  F Bock; Y König; T Dietrich; P Zimmermann; M Baier; C Cursiefen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

Review 4.  [Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)].

Authors:  D Hos; T H van Essen; F Bock; C-H Chou; H-A Pan; C-C Lin; M-C Huang; S-C Chen; C Cursiefen; M J Jager
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

5.  Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease.

Authors:  Amadeus E Altenburger; Björn Bachmann; Berthold Seitz; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-15       Impact factor: 3.117

6.  [Retained Descemet's membrane after penetrating keratoplasty for macular corneal dystrophy].

Authors:  L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

7.  Posttransplant VEGFR1R2 Trap Eye Drops Inhibit Corneal (Lymph)angiogenesis and Improve Corneal Allograft Survival in Eyes at High Risk of Rejection.

Authors:  Wei Zhang; Alfrun Schönberg; Felix Bock; Claus Cursiefen
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.